Haleon PLC (HLN)
8.32
-0.03
(-0.36%)
USD |
NYSE |
May 02, 16:00
8.32
0.00 (0.00%)
After-Hours: 16:19
Haleon SG&A Expense (Quarterly): 1.357B for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.357B |
September 30, 2023 | 1.340B |
June 30, 2023 | 1.411B |
March 31, 2023 | 1.380B |
December 31, 2022 | 1.773B |
Date | Value |
---|---|
September 30, 2022 | 1.408B |
June 30, 2022 | 1.374B |
March 31, 2022 | 1.457B |
December 31, 2021 | 958.45M |
September 30, 2021 | 1.375B |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
958.45M
Minimum
Dec 2021
1.773B
Maximum
Dec 2022
1.383B
Average
1.377B
Median
SG&A Expense (Quarterly) Benchmarks
GSK PLC | 3.326B |
Pfizer Inc | 4.575B |
AstraZeneca PLC | 4.63B |
Verona Pharma PLC | 14.97M |
Adaptimmune Therapeutics PLC | 16.88M |